Literature DB >> 651284

Antigenic relationship between Chang liver cells and human hepatocytes.

T H Hütteroth, K H Meyer.   

Abstract

Using monospecific antisera against human liver specific protein (LSP) it could be demonstrated that Chang liver cells bear LSP on their membranes. Chang liver cells can therefore be used as in vitro system to study immune reactions against LSP in human inflammatory liver diseases.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 651284     DOI: 10.1007/BF01492866

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Detection of circulating immune complexes with a modified Raji cell technique.

Authors:  T H Hütteroth; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1977-09-15

2.  Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.

Authors:  K Thestrup-Pedersen; K Ladefoged; P Andersen
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

3.  Studies on plasma membranes from liver cells. Separation and characterization of lipoprotein subunits of the isolated plasma membranes.

Authors:  M Barclay; R K Barclay; V P Skipski; E S Essner; O Terebus-Kekish
Journal:  Biochim Biophys Acta       Date:  1972-03-17

4.  Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis.

Authors:  A D Thomson; M A Cochrane; I G McFarlane; A L Eddleston; R Williams
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

5.  [Cellular immune reactions towards homologous liver-specific antigens (HLP) in chronic inflammatory liver diseases (author's transl)].

Authors:  K H von Meyer zum Büschenfelde; J Knolle; J Berger
Journal:  Klin Wochenschr       Date:  1974-03-01

6.  Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. II. Demonstration of immunoglobulin on isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde
Journal:  Br J Exp Pathol       Date:  1974-10

7.  Liver specific antigens. Purification and characterization.

Authors:  P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

8.  Organ-specificity and diagnostic value of cell-mediated immunity against a liver-specific membrane protein: studies in hepatic and non-hepatic diseases.

Authors:  K H Meyer zum Büschenfelde; A Alberti; W Arnold; J Freudenberg
Journal:  Klin Wochenschr       Date:  1975-11-15

9.  Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis.

Authors:  J Miller; M G Smith; C G Mitchell; W D Reed; A L Eddleston; R Williams
Journal:  Lancet       Date:  1972-08-12       Impact factor: 79.321

10.  Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis.

Authors:  K R Wands; K J Isselbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  4 in total

1.  Studies on ADCC assay using antigen-coated cells as target for detection of anti-LP-1 and anti-Tamm-Horsfall glycoprotein.

Authors:  H Shimomura
Journal:  Gastroenterol Jpn       Date:  1982-04

Review 2.  The role of liver membrane antigens as targets in autoimmune type liver disease.

Authors:  K H Meyer zum Büschenfelde; T H Hütteroth; M Manns; B Möller
Journal:  Springer Semin Immunopathol       Date:  1980-12

3.  Detection of antibodies to Chang liver cell in sera from patients with chronic liver diseases by 125I-labelled protein A binding assay and the effect of prednisolone and 6-mercaptopurine treatment on the level of the antibodies.

Authors:  Y Inagaki; T Morizane; S Matsumura; N Kawamura; T Watanabe; N Kumagai; T Nakamura; K Tsuchimoto; M Tsuchiya
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

4.  Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis.

Authors:  T H Hütteroth; T Poralla; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.